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INTRODUCTION 
Atherosclerosis (ATH) is recognized as a chronic inflammatory condition and it is the leading cause of cardiovascular disease. The process of atherogenesis is characterized by the 
accumulation and oxidation of LDL (oxLDL) in the vessel wall and subsequent infiltration and activation of immune cells, particularly monocytes in an earlier stage and, later on, 
lymphocytes.  The infiltrated monocytes differentiate into macrophages which then could differentiate into foam cells as a consequence of oxLDL uptake [1]. The recruitment of immune 
cells to the site of ATH lesion contributes to a local pro-inflammatory state that will promote the development of the atheroma plaque and progression of the disease. However, the exact 
mechanisms involved in this process are not fully understood. One hypothesis is the contribution of oxidative stress mediated by metals such as iron [2]. Previous authors have shown 
high iron content in foam cells and also accumulation of hemoglobin and ferritin in the areas rich in foam cells [3]. Herein, we investigate a possible mechanism for cellular iron 
accumulation by testing the effect of pro-inflammatory as well as pro-atherogenic stimuli in the expression of proteins involved in iron efflux in  macrophages. 
Mouse bone marrow-derived macrophages (BMDM) were prepared from SWISS mice (7-11 weeks of age) as previously described [4]. Briefly, bone marrow cells were extracted from 
femurs and cultured in RPMI 1640 medium supplemented with 10% FBS, 10% LCCM and 1% antibiotics for 7 days for complete differentiation into macrophages before experiments. 
BMDM were then treated with LPS (10ng/mL; 20h) , iron (Fe-NTA 100 µM, 20h) or/and oxLDL (50 µg/mL; 24h). The expression of ferroportin (Fpn, iron exporter), beta-amyloid precursor 
protein (APP, ferroxidase), ceruloplasmin (Cp, ferroxidase) were analyzed by western blot of subcellular fractions (cytosol, membrane extracts and lipid raft fractions DRM prepared as 
described previously [5]). Oil Red O staining  (lipid specific dye)  and hematoxylin counterstain was used to follow foam cell differentiation by oxLDL treatment.  Antibodies used: Home 
made polyclonal rabbit anti-mouse Fpn [6];  monoclonal mouse  anti-APP (Dilution 1/500, clone 22C11, Millipore);  polyclonal rabbit anti-caveolin1 (1/500 to 1/10000, Santa Cruz) and  
polyclonal goat anti-human Cp (1/100, KOMA BIOTECH INC.) 
MATERIAL & METHODS 
ANALYSIS OF RESULTS 
APP is expressed in  mouse BMDM and is upregulated by iron 
Fig.1 – Analysis of protein 
expression in mouse BMDM by 
Western Blot. Immunoblotting 
analysis showed that Cp is 
upregulated by LPS in both 
membrane and cytosol extracts 
whereas Fpn is downregulated by 
LPS and upregulated by iron 
overload as previously reported 
[4;6].  APP is only slightly 
upregulated by LPS compared to 
Cp, but it is strongly upregulated 
by iron overload like Fpn.   
 
APP and  Fpn are localized in lipid raft  in iron-treated BMDM 
Fig.2 – Expression  of Fpn, APP and Caveolin-1 (Cav-1) in detergent resistant 
membranes (DRM : lipid raft) from BMDM after iron (Fe-NTA) or LPS treatment.  
Immunoblotting analysis of Cav-1 (raft marker) in BMDM iodixanol fractions showed 
that fractions 1-4 are enriched in DRM proteins, with fractions 5 and 6 being enriched 
in Cav-1 due to higher protein concentration in these fractions (protein retention in 
interface 20%-30% of iodixanol layers). In untreated BMDM (A), APP is mostly 
expressed in fractions 5-11 while Fpn is more expressed in fractions 7-10. In iron-
treated BMDM (B), recruitment to lipid rafts/DRM  fractions of both APP and Fpn is 
observed. In LPS-treated BMDM (C), Fpn expression was downregulated whereas 
APP expression was slightly increased when compared to untreated cells.  The protein 
concentration in the different  iodixanol gradient fractions was calculated by Bradford 
quantification  method and is represented in the graphics at the bottom of each 
gradient. The pattern of protein distribution showed the protein  retention in fractions 5-
6 and high concentration of proteins in  the  fractions 9-12 corresponding to Non-
Detergent Resistant Membranes and cytosolic proteins. Since the protein content in 
DRM fractions 1-4 is low, detection of APP and Fpn in these fractions suggest a strong 
enrichment of these proteins in DRM.  
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Cp and APP, both ferroxidases  reported to  interact with  Fpn, are differentially regulated  by LPS and iron in BMDM, with Cp being strongly upregulated by LPS and APP by iron 
overload. Previously, we have reported that  membrane Cp and Fpn were  only partially colocalized in BMDM and proposed that other ferroxidases could be interacting with Fpn for iron 
export [7]. Considering  that Fpn is upregulated by iron,  APP  is a potential partner for Fpn in BMDM. Supporting this hypothesis, we observe that after iron treatment, APP is  recruited in 
DRM/lipid rafts fractions along with Fpn. Modulation of protein involved in iron export  by  inflammatory stimuli could also contribute to disruption of iron metabolism in plaque 
macrophages. In addition, foam cell differentiation of BMDM by oxLDL was enhanced in the presence of iron overload, supporting the idea that iron overload in atheroma plaques may 
constitute a pro-atherogenic  factor.  Moreover, the effect of oxLDL  on the expression and localization of iron-related proteins on lipid raft microdomains may constitute an important 
pathway for iron efflux disruption in the plaque environment and is  currently  being investigated. 
CONCLUSIONS 
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Fig.3 – Effect of iron 
overload on BMDM 
differentiation into foam 
cells. BMDM were treated 
for 24h with no stimuli  (A) 
or with Fe-NTA (B, 100 µM) 
or  oxLDL (C, 50 µg/ml) or 
both Fe-NTA and oxLDL 
(D).  Foam cells differen-
tiation (red staining) was 
only observed in the 
presence of oxLDL and was 
enhanced in the presence 
of iron (Fe-NTA), sugges-
ting an atherogenic role of 
iron overload in foam cell 
differentiation.  
BMDM differentiation into foam cell is enhanced by iron overload  
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